Efficacy of Adding Veliparib to Temozolomide for Patients With MGMT-Methylated Glioblastoma
      QxMD      Google Scholar   
Citation:
JAMA Oncol
Year:
2024
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
3729  
Children:
None
Program:
OGC
Primary Committee:
Neuro-Onc
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U24CA196171, UG1CA232760, UG1CA233329, U10CA180868 (NRG Oncology), U10CA180888 (SWOG)  
Corr. Author:
 
Authors:
                                                 
Networks:
CA136, CA249, ESSENTIA, KAISER, LAPS-IL036, LAPS-MN026, LAPS-PA015, LAPS-TX035   
Study
Alliance-A071102
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2/3
Keywords: